FORTROSS BONE VOID FILLER

K110561 · Pioneer Surgical Technology · MQV · Apr 29, 2011 · Orthopedic

Device Facts

Record IDK110561
Device NameFORTROSS BONE VOID FILLER
ApplicantPioneer Surgical Technology
Product CodeMQV · Orthopedic
Decision DateApr 29, 2011
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3045
Device ClassClass 2
AttributesTherapeutic

Intended Use

FortrOss Bone Void Filler is indicated for bony voids or gaps that are not intrinsic to the stability of bony structure. These defects may be surgically created osseous defects or defects created from traumatic injury to the bone. The product is indicated to be used in the posterolateral spine in conjunction with bone marrow aspirate and autograft bone. The product provides a bone void filler that resorbs and is replaced with bone during the healing process.

Device Story

FortrOss Bone Void Filler is a resorbable, radiopaque, granular bone graft substitute composed of calcium phosphate in a porcine gelatin carrier. Used by surgeons in clinical settings for filling non-structural bony voids or gaps, specifically in the posterolateral spine. The device is mixed with bone marrow aspirate and autograft bone at the time of implantation using an included mixing chamber and placed via an accessory tool. It acts as a scaffold that resorbs over time, facilitating replacement with natural bone during the healing process. This modification introduces a 20 cc size, a new mixing chamber, and a placement accessory.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Resorbable calcium phosphate in porcine gelatin carrier; granular form; radiopaque; sterile; single-use. Includes mixing chamber and placement accessory. No software or electronic components.

Indications for Use

Indicated for patients with bony voids or gaps not intrinsic to structural stability, including surgically created osseous defects or traumatic bone injuries. Intended for use in the posterolateral spine with bone marrow aspirate and autograft bone.

Regulatory Classification

Identification

A resorbable calcium salt bone void filler device is a resorbable implant intended to fill bony voids or gaps of the extremities, spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure.

Special Controls

*Classification.* Class II (special controls). The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance: Resorbable Calcium Salt Bone Void Filler Device; Guidance for Industry and FDA.” See § 888.1(e) of this chapter for the availability of this guidance.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ KII0561 #### Special 510(k): Device Modification FortrOss Bone Void Filler # APR 2 9 2011 ## 510(k) Summary # Pioneer Surgical Technology Special 510(k): Device Modification ## FortrOss Bone Void Filler ## ADMINISTRATIVE INFORMATION Manufacturer Name: 375 River Park Circle Marquette, MI 49855 +1 (906) 226-4812 Telephone: Fax: +1 (906) 226-4459 Pioneer Surgical Technology Official Contact: Representative/Consultant: Jonathan Gilbert David J. Collette, MD or Floyd G. Larson PaxMed International, LLC 11234 El Camino Real, Suite 200 San Diego, CA 92130 Telephone: +1 (858) 792-1235 +1 (858) 792-1236 Fax: Email: dcollette@paxmed.com flarson@paxmed.com #### DEVICE NAME AND CLASSIFICATION Trade/Proprietary Name: Common Name: Classification Regulations: Product Code: Classification Panel: Reviewing Branch: FortrOss Bone Void Filler Bone Void Filler Filler, Bone Void, Calcium Compound 21 CFR 888.3045, Class II MQV Orthopaedic and Rehabilitation Devices Restorative Devices Branch Image /page/0/Picture/18 description: The image shows the text "Page 17 of 86 pg 1 of 2". The words "Page 17 of 86" have a line through them. The text appears to be handwritten. {1}------------------------------------------------ Special 510(k); Device Modification FortrOss Bone Void Filler #### INTENDED USE FortrOss Bone Void Filler is indicated for bony voids or gaps that are not intrinsic to the stability of bony structure. These defects may be surgically created osseous defects or defects created from traumatic injury to the bone. The product is indicated to be used in the posterolateral spine in conjunction with bone marrow aspirate and autograft bone. The product provides a bone void filler that resorbs and is replaced with bone during the healing process. ### DEVICE DESCRIPTION FortrOss Bone Void Filler is a resorbable bone void filler consisting of calcium phosphate in a porcine gelatin carrier provided in granular form. FortrOss Bone Void Filler is radiopaque, provided sterile and is intended for single use only. ### PREDICATE DEVICE #### K091031 - Pioneer FortrOss Bone Void Filler ### COMPARISON TO MARKETED DEVICE The intended use and composition of this device are identical to those of the predicate. This submission introduces a larger (20 cc) product size, a packaging modification consisting of a mixing chamber intended to facilitate reconstitution of the device at the time of implantation, and an accessory to facilitate placement of the device along the posterolateral spine. #### PERFORMANCE TESTING Non-clinical evaluation consisting of material specifications and engineering design review and validation relevant to the line extensions described above were performed. #### CONCLUSION Based on information presented in this submission, we conclude that the FortrOss Bone Void Filler is substantially equivalent to predicate device. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wings. The eagle faces right and is positioned within a circular border. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper portion of the circle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 APR 2 9 2011 Pioneer Surgical Technology % PaxMed international, LLC David J. Collette, M.D. 11234 El Camino Real, Suite 200 San Diego, California 92130 Re: K110561 Trade/Device Name: FortrOss Bone Void Filler Regulation Number: 21 CFR 888.3045 Regulation Name: Resorbable calcium salt bone void filler device Regulatory Class: II Product Code: MOV Dated: March 31, 2011 Received: April 1, 2011 - Dear Dr. Collette: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - David J. Collette, M.D. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information-on-your-responsibilities under the Act-from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, A B. R for Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ FortrOss Bone Void Filler # Indications for Use 510(k) Number: K110261 Device Name: FortrOss Bone Void Filler Indications for Use FortrOss Bone Void Filler is indicated for bony voids or gaps that are not intrinsic to the stability of bony structure. These defects may be surgically created osseous defects or defects created from traumatic injury to the bone. The product is indicated to be used in the posterolateral spine in conjunction with bone marrow aspirate and autograft bone. The product provides a bone void filler that resorbs and is replaced with bone during the healing process. Prescription Use _____________________________________________________________________________________________________________________________________________________________ X (21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Division Sigr (Division Sign-On), Orthopedia Division of Surgical, Orthopedia Devision of Surgical, Devices DIVIsion of Surges Image /page/4/Picture/14 description: The image shows the text 'K110561' with a line underneath it. The text is handwritten and appears to be a code or identification number. The text is positioned to the right of the word 'number'. Page 1 of 510(k) Number .
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from the tree

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...